Internal Medicine, Cardiovascular Disease · Birmingham, AL
NPI
1770548307
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
801 Princeton Ave SW, Sute 706
Birmingham, AL, 35211
Phone (205) 780-4330
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.0M
13,004 services
Medicare patients, 2024
823
Average age 76
Drug cost, 2024
$3.1M
18,408 prescriptions
Company payments, 2025
$479
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Farrell O Mendelsohn was code 93000 (electrocardiogram), 1,637 times for 756 patients. In total Farrell O Mendelsohn billed 13,004 services in 76 codes, and Medicare paid $1.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-09-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93000 Electrocardiogram | Office | 1,637 | 756 | $8.78 | $14K |
| 99214 Office E&M - Established | Office | 1,581 | 718 | $77.97 | $123K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 1,228 | 301 | $4.98 | $6,121 |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 586 | 288 | $230.65 | $135K |
| 93306 Echocardiography (TTE/TEE) | Office | 568 | 552 | $121.22 | $69K |
| 99233 Hospital E&M - Subsequent | Facility | 325 | 78 | $85.97 | $28K |
| 93015 Electrocardiogram | Office | 321 | 312 | $49.08 | $16K |
| 93296 External Electrocardiographic Monitoring | Office | 303 | 89 | $13.05 | $3,955 |
| 78431 Myocardial Perfusion Scan | Office | 296 | 291 | $1,600.51 | $474K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 197 | 189 | $121.00 | $24K |
| 93294 External Electrocardiographic Monitoring | Office | 184 | 52 | $19.55 | $3,597 |
| 93922 Duplex Scan - Extremity Arteries | Office | 158 | 156 | $48.94 | $7,732 |
| 93295 External Electrocardiographic Monitoring | Office | 121 | 38 | $23.51 | $2,845 |
| 99152 Anesthesia | Facility | 107 | 95 | $8.68 | $928 |
| 93970 Duplex Scan - Extremity Veins | Office | 89 | 88 | $120.66 | $11K |
By year: 2022 $1.2M for 10,593 services; 2023 $1.4M for 11,553 services; 2024 $1.0M for 13,004 services.
Medicare prescription drug claims, 2024
In 2024, the drug Farrell O Mendelsohn prescribed most often to Medicare patients was Eliquis (Apixaban), with 1,358 prescriptions and refills. In total Farrell O Mendelsohn wrote 18,408 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 1,358 | 1,710 | 244 | $985K |
| Metoprolol Succinate Generic | 1,136 | 2,674 | 310 | $21K |
| Clopidogrel Clopidogrel Bisulfate | 1,037 | 2,341 | 293 | $11K |
| Spironolactone Generic | 978 | 2,066 | 266 | $6,311 |
| Atorvastatin Calcium Generic | 922 | 2,400 | 289 | $14K |
| Amlodipine Besylate Generic | 895 | 2,077 | 278 | $5,440 |
| Losartan Potassium Generic | 864 | 2,155 | 264 | $12K |
| Farxiga Dapagliflozin Propanediol | 853 | 1,004 | 157 | $549K |
| Carvedilol Generic | 589 | 1,431 | 173 | $5,077 |
| Repatha Sureclick Evolocumab | 552 | 643 | 94 | $353K |
| Rosuvastatin Calcium Generic | 535 | 1,237 | 150 | $11K |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 499 | 1,113 | 144 | $7,794 |
| Entresto Sacubitril/Valsartan | 481 | 626 | 98 | $377K |
| Nitroglycerin Generic | 456 | 503 | 246 | $8,760 |
| Ranolazine Er Ranolazine | 441 | 785 | 107 | $43K |
Brand drugs: 4,163 claims; generic drugs: 14,245 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Farrell O Mendelsohn $479 ($479 in general payments such as food, travel and fees) from 14 companies. The largest payer was Pfizer Inc. with $138.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 7 | $138 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $58.52 |
| Novo Nordisk Inc NVO | 3 | $46.49 |
| Amgen Inc. AMGN | 3 | $43.94 |
| Biosense Webster, Inc. JNJ | 1 | $40.34 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $39.57 |
| Actelion Pharmaceuticals US, Inc. JNJ | 2 | $35.93 |
| AngioDynamics, Inc. ANGO | 1 | $29.7 |
| Lexicon Pharmaceuticals, Inc. LXRX | 1 | $20.19 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $16.13 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.